Markets
Globus Medical Stock Plunges 8.48% After Sales Forecast Cut — Erasing $928 Million
Management blamed launch delays and weak recruiting for the sales cut, while keeping its adjusted earnings outlook unchanged.
Globus Medical (GMED) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
Markets
Management blamed launch delays and weak recruiting for the sales cut, while keeping its adjusted earnings outlook unchanged.
Earnings
CEO Keith Pfeil blamed delayed launches and weak rep recruiting, not the market, for a third quarter that cut guidance from $3.18 billion to $3.22 billion.